BDSI
$6.18
Biodelivery Sci Intl
($.03)
(.48%)
BDSI
Earnings Whisper ®
N/A
4th Quarter December 2019
Consensus:  $0.01
Revenue:  $31.20 Mil
Tuesday
Feb 11
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BDSI reports earnings?
Beat
Meet
Miss

Where is BDSI's stock price going from here?
Up
Flat
Down
Stock chart of BDSI
Analysts
Summary of analysts' recommendations for BDSI
Score
Grade
Pivots
Resistance
$6.50
$6.43
$6.32

$6.25

Support
$6.14
$6.07
$5.96
Tweet
Growth
Description
BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any process, substance, or combination thereof, that delivers drugs into the body.
Peers
BioMarin PharmaceuticalRegeneron PharmaceuticalsVertex PharmaceuticalsInterCeptJohnson & JohnsonZoetisEndo International plcMylanUltragenyx PharmaceuticalMedicines